LICC: L-BLP25 in patients with colorectal carcinoma after curative resection of hepatic metastases - a randomized, placebo-controlled, multicenter, multinational, double blinded phase II trial
Laufzeit: 01.01.2023 - 31.12.2023
imported
Kurzfassung
-